More Myocarditis...
Media Reports, Histopathologic Analysis, Prospective Studies, and Passive Surveillance Data Point to the Same Conclusion: Gene Therapy Products (GTPs BNT162b2 and mRNA1273, etc.) Damage Hearts.
LNP/mRNA is widely distributed. Manifestations of tissue and organ harms produced by multiple pathological processes are also highly varied. Heart disease along with strokes, seizures, unusual clotting and bleeding and turbo cancer are the most dramatic of the CoVax Disease group.
In the News,
Histopathology: Myocarditis/pericarditis is a special case of muscle involvement after injection of GTPs.
The slide below illustrates lymphocytic infiltration of heart, skeletal muscle, and the muscle layers of intestine and arteries.
From the Burkhardt collection:
Prospective Peer Reviewed Study: Mueller and colleagues using sensitive methodology found that females had more myocarditis after GTPs than males, Females 3.7% vs. Males 0.8%.
(URL and pdf for Mueller, et al.),
a. https://onlinelibrary.wiley.com/doi/10.1002/ejhf.2978
b. European J of Heart Fail - 2023 - Buergin - Sex‐specific differences in myocardial injury incidence after COVID‐19.pdf
However, VAERS reporting of myo/pericarditis is strongly male dominated.
VAERS Age Data,
The median age in the Mueller, et al. study was 46. The most at risk brackets may not have been well represented compared with all ages in VAERS. The average age in the Barmada study (see below) was 16.9 years with a range of 13-21 years of age and 87% were male (20/23).
Females may have more cases of myo/pericarditis but males have more severe cases.
Passive Data Collection: Vaccine Adverse Event Reporting System (VAERS) comparison of C19 gene therapy products with flu vaccine (top) and all vaccines (bottom),
The green column is myocarditis events in 2021 when mass inoculation with GTPs occurred.
Severity is vastly greater in other data sets and not all patients recover.
a. From Cho, et al. https://academic.oup.com/eurheartj/advance-article. /doi/10.1093/eurheartj/ehad339/7188747
b. From Barmada, et al. https://www.science.org/doi/full/10.1126/sciimmunol.adh3455
Cardiac function as measured by how much blood is pumped out of the ventricles (RVEF = Right Ventricle Ejection Fraction, LVEF = Left Ventricle Ejection Fraction) and scarring two months or later after diagnosis,
i. RVEF: Two patients had normal values at follow-up. Seven had lower EFs after “recovery,” and seven improved but were below 55% at follow-up.
ii. LVEF: Seven patients were in the normal range during hospitalization and after at least two months. Three patients improved, and nine declined.
iii. Fifteen of 17 patients had Late Gadolinium Enhancement (LGE) in the acute phase of their illness and 14 of 17 began or continued to have LGE after their “recovery”. Three patients went from positive to negative and two went from negative to positive.
These products must be taken off the market. Research into the harms they have produced must be intensified. Recognition and treatment of persons harmed must be improved.
Hannah Arendt interview on display with the Exhibit,
at the Ronald Reagan Presidential Library and Museum, Simi Valley, California, July 25, 2023.
Wen gallows?